img

Global IBS Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global IBS Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
IBS Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global IBS Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global IBS Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Allergan (Ireland)
Sucampo Pharmaceuticals (U.S.)
Ironwood Pharmaceuticals (U.S.)
Astellas Pharma (Japan)
Bausch Health
Abbott Laboratories (U.S.)
Synergy Pharmaceuticals (U.S.)
Ardelyx (U.S.)
Nestle (Switzerland)
Sebela Pharmaceuticals (Ireland)
Probi (Sweden)
Alfasigma USA (Italy)
RedHill Biopharma (Israel)
AstraZeneca (U.K)
Ipsen (France)
Novartis (Switzerland)
Takeda Pharmaceutical Company (Japan)
Synthetic Biologics (U.S.)
Protagonist Therapeutics (U.S.)
Pfizer (U.S.)
Lexicon Pharmaceuticals (U.S.)
Innovate Biopharmaceuticals (U.S.)
Segment by Type
IBS-D
IBS-C
IBS-M

Segment by Application


Hospitals
Clinics
Research Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the IBS Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, IBS Treatment introduction, etc. IBS Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of IBS Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of IBS Treatment
1.1 IBS Treatment Market Overview
1.1.1 IBS Treatment Product Scope
1.1.2 IBS Treatment Market Status and Outlook
1.2 Global IBS Treatment Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global IBS Treatment Market Size by Region (2024-2034)
1.4 Global IBS Treatment Historic Market Size by Region (2024-2024)
1.5 Global IBS Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, IBS Treatment Market Size (2024-2034)
1.6.1 North America IBS Treatment Market Size (2024-2034)
1.6.2 Europe IBS Treatment Market Size (2024-2034)
1.6.3 Asia-Pacific IBS Treatment Market Size (2024-2034)
1.6.4 Latin America IBS Treatment Market Size (2024-2034)
1.6.5 Middle East & Africa IBS Treatment Market Size (2024-2034)
2 IBS Treatment Market by Type
2.1 Introduction
2.1.1 IBS-D
2.1.2 IBS-C
2.1.3 IBS-M
2.2 Global IBS Treatment Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global IBS Treatment Historic Market Size by Type (2024-2024)
2.2.2 Global IBS Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America IBS Treatment Revenue Breakdown by Type (2024-2034)
2.3.2 Europe IBS Treatment Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific IBS Treatment Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America IBS Treatment Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa IBS Treatment Revenue Breakdown by Type (2024-2034)
3 IBS Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Research Laboratories
3.2 Global IBS Treatment Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global IBS Treatment Historic Market Size by Application (2024-2024)
3.2.2 Global IBS Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America IBS Treatment Revenue Breakdown by Application (2024-2034)
3.3.2 Europe IBS Treatment Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific IBS Treatment Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America IBS Treatment Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa IBS Treatment Revenue Breakdown by Application (2024-2034)
4 IBS Treatment Competition Analysis by Players
4.1 Global IBS Treatment Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IBS Treatment as of 2022)
4.3 Date of Key Players Enter into IBS Treatment Market
4.4 Global Top Players IBS Treatment Headquarters and Area Served
4.5 Key Players IBS Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 IBS Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Allergan (Ireland)
5.1.1 Allergan (Ireland) Profile
5.1.2 Allergan (Ireland) Main Business
5.1.3 Allergan (Ireland) IBS Treatment Products, Services and Solutions
5.1.4 Allergan (Ireland) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.1.5 Allergan (Ireland) Recent Developments
5.2 Sucampo Pharmaceuticals (U.S.)
5.2.1 Sucampo Pharmaceuticals (U.S.) Profile
5.2.2 Sucampo Pharmaceuticals (U.S.) Main Business
5.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
5.2.4 Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.2.5 Sucampo Pharmaceuticals (U.S.) Recent Developments
5.3 Ironwood Pharmaceuticals (U.S.)
5.3.1 Ironwood Pharmaceuticals (U.S.) Profile
5.3.2 Ironwood Pharmaceuticals (U.S.) Main Business
5.3.3 Ironwood Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
5.3.4 Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.3.5 Astellas Pharma (Japan) Recent Developments
5.4 Astellas Pharma (Japan)
5.4.1 Astellas Pharma (Japan) Profile
5.4.2 Astellas Pharma (Japan) Main Business
5.4.3 Astellas Pharma (Japan) IBS Treatment Products, Services and Solutions
5.4.4 Astellas Pharma (Japan) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.4.5 Astellas Pharma (Japan) Recent Developments
5.5 Bausch Health
5.5.1 Bausch Health Profile
5.5.2 Bausch Health Main Business
5.5.3 Bausch Health IBS Treatment Products, Services and Solutions
5.5.4 Bausch Health IBS Treatment Revenue (US$ Million) & (2024-2024)
5.5.5 Bausch Health Recent Developments
5.6 Abbott Laboratories (U.S.)
5.6.1 Abbott Laboratories (U.S.) Profile
5.6.2 Abbott Laboratories (U.S.) Main Business
5.6.3 Abbott Laboratories (U.S.) IBS Treatment Products, Services and Solutions
5.6.4 Abbott Laboratories (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.6.5 Abbott Laboratories (U.S.) Recent Developments
5.7 Synergy Pharmaceuticals (U.S.)
5.7.1 Synergy Pharmaceuticals (U.S.) Profile
5.7.2 Synergy Pharmaceuticals (U.S.) Main Business
5.7.3 Synergy Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
5.7.4 Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.7.5 Synergy Pharmaceuticals (U.S.) Recent Developments
5.8 Ardelyx (U.S.)
5.8.1 Ardelyx (U.S.) Profile
5.8.2 Ardelyx (U.S.) Main Business
5.8.3 Ardelyx (U.S.) IBS Treatment Products, Services and Solutions
5.8.4 Ardelyx (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.8.5 Ardelyx (U.S.) Recent Developments
5.9 Nestle (Switzerland)
5.9.1 Nestle (Switzerland) Profile
5.9.2 Nestle (Switzerland) Main Business
5.9.3 Nestle (Switzerland) IBS Treatment Products, Services and Solutions
5.9.4 Nestle (Switzerland) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.9.5 Nestle (Switzerland) Recent Developments
5.10 Sebela Pharmaceuticals (Ireland)
5.10.1 Sebela Pharmaceuticals (Ireland) Profile
5.10.2 Sebela Pharmaceuticals (Ireland) Main Business
5.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Products, Services and Solutions
5.10.4 Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.10.5 Sebela Pharmaceuticals (Ireland) Recent Developments
5.11 Probi (Sweden)
5.11.1 Probi (Sweden) Profile
5.11.2 Probi (Sweden) Main Business
5.11.3 Probi (Sweden) IBS Treatment Products, Services and Solutions
5.11.4 Probi (Sweden) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.11.5 Probi (Sweden) Recent Developments
5.12 Alfasigma USA (Italy)
5.12.1 Alfasigma USA (Italy) Profile
5.12.2 Alfasigma USA (Italy) Main Business
5.12.3 Alfasigma USA (Italy) IBS Treatment Products, Services and Solutions
5.12.4 Alfasigma USA (Italy) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.12.5 Alfasigma USA (Italy) Recent Developments
5.13 RedHill Biopharma (Israel)
5.13.1 RedHill Biopharma (Israel) Profile
5.13.2 RedHill Biopharma (Israel) Main Business
5.13.3 RedHill Biopharma (Israel) IBS Treatment Products, Services and Solutions
5.13.4 RedHill Biopharma (Israel) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.13.5 RedHill Biopharma (Israel) Recent Developments
5.14 AstraZeneca (U.K)
5.14.1 AstraZeneca (U.K) Profile
5.14.2 AstraZeneca (U.K) Main Business
5.14.3 AstraZeneca (U.K) IBS Treatment Products, Services and Solutions
5.14.4 AstraZeneca (U.K) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.14.5 AstraZeneca (U.K) Recent Developments
5.15 Ipsen (France)
5.15.1 Ipsen (France) Profile
5.15.2 Ipsen (France) Main Business
5.15.3 Ipsen (France) IBS Treatment Products, Services and Solutions
5.15.4 Ipsen (France) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.15.5 Ipsen (France) Recent Developments
5.16 Novartis (Switzerland)
5.16.1 Novartis (Switzerland) Profile
5.16.2 Novartis (Switzerland) Main Business
5.16.3 Novartis (Switzerland) IBS Treatment Products, Services and Solutions
5.16.4 Novartis (Switzerland) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.16.5 Novartis (Switzerland) Recent Developments
5.17 Takeda Pharmaceutical Company (Japan)
5.17.1 Takeda Pharmaceutical Company (Japan) Profile
5.17.2 Takeda Pharmaceutical Company (Japan) Main Business
5.17.3 Takeda Pharmaceutical Company (Japan) IBS Treatment Products, Services and Solutions
5.17.4 Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.17.5 Takeda Pharmaceutical Company (Japan) Recent Developments
5.18 Synthetic Biologics (U.S.)
5.18.1 Synthetic Biologics (U.S.) Profile
5.18.2 Synthetic Biologics (U.S.) Main Business
5.18.3 Synthetic Biologics (U.S.) IBS Treatment Products, Services and Solutions
5.18.4 Synthetic Biologics (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.18.5 Synthetic Biologics (U.S.) Recent Developments
5.19 Protagonist Therapeutics (U.S.)
5.19.1 Protagonist Therapeutics (U.S.) Profile
5.19.2 Protagonist Therapeutics (U.S.) Main Business
5.19.3 Protagonist Therapeutics (U.S.) IBS Treatment Products, Services and Solutions
5.19.4 Protagonist Therapeutics (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.19.5 Protagonist Therapeutics (U.S.) Recent Developments
5.20 Pfizer (U.S.)
5.20.1 Pfizer (U.S.) Profile
5.20.2 Pfizer (U.S.) Main Business
5.20.3 Pfizer (U.S.) IBS Treatment Products, Services and Solutions
5.20.4 Pfizer (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.20.5 Pfizer (U.S.) Recent Developments
5.21 Lexicon Pharmaceuticals (U.S.)
5.21.1 Lexicon Pharmaceuticals (U.S.) Profile
5.21.2 Lexicon Pharmaceuticals (U.S.) Main Business
5.21.3 Lexicon Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
5.21.4 Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.21.5 Lexicon Pharmaceuticals (U.S.) Recent Developments
5.22 Innovate Biopharmaceuticals (U.S.)
5.22.1 Innovate Biopharmaceuticals (U.S.) Profile
5.22.2 Innovate Biopharmaceuticals (U.S.) Main Business
5.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
5.22.4 Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue (US$ Million) & (2024-2024)
5.22.5 Innovate Biopharmaceuticals (U.S.) Recent Developments
6 North America
6.1 North America IBS Treatment Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe IBS Treatment Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific IBS Treatment Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America IBS Treatment Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa IBS Treatment Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 IBS Treatment Market Dynamics
11.1 IBS Treatment Industry Trends
11.2 IBS Treatment Market Drivers
11.3 IBS Treatment Market Challenges
11.4 IBS Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market IBS Treatment Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global IBS Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global IBS Treatment Market Size Share by Region (2024-2024)
Table 4. Global IBS Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global IBS Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global IBS Treatment Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global IBS Treatment Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global IBS Treatment Revenue Market Share by Type (2024-2024)
Table 9. Global IBS Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global IBS Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America IBS Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America IBS Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe IBS Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe IBS Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific IBS Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific IBS Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America IBS Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America IBS Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa IBS Treatment Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa IBS Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global IBS Treatment Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global IBS Treatment Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global IBS Treatment Revenue Market Share by Application (2024-2024)
Table 24. Global IBS Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global IBS Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America IBS Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America IBS Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe IBS Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe IBS Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific IBS Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific IBS Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America IBS Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America IBS Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa IBS Treatment Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa IBS Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global IBS Treatment Revenue (US$ Million) by Players (2024-2024)
Table 37. Global IBS Treatment Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IBS Treatment as of 2022)
Table 39. Date of Key Players Enter into IBS Treatment Market
Table 40. Global IBS Treatment Key Players Headquarters and Area Served
Table 41. IBS Treatment Product Solution and Service
Table 42. Global IBS Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Allergan (Ireland) Basic Information List
Table 45. Allergan (Ireland) Description and Business Overview
Table 46. Allergan (Ireland) IBS Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in IBS Treatment Business of Allergan (Ireland) (2024-2024)
Table 48. Allergan (Ireland) Recent Developments
Table 49. Sucampo Pharmaceuticals (U.S.) Basic Information List
Table 50. Sucampo Pharmaceuticals (U.S.) Description and Business Overview
Table 51. Sucampo Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in IBS Treatment Business of Sucampo Pharmaceuticals (U.S.) (2024-2024)
Table 53. Sucampo Pharmaceuticals (U.S.) Recent Developments
Table 54. Ironwood Pharmaceuticals (U.S.) Basic Information List
Table 55. Ironwood Pharmaceuticals (U.S.) Description and Business Overview
Table 56. Ironwood Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in IBS Treatment Business of Ironwood Pharmaceuticals (U.S.) (2024-2024)
Table 58. Ironwood Pharmaceuticals (U.S.) Recent Developments
Table 59. Astellas Pharma (Japan) Basic Information List
Table 60. Astellas Pharma (Japan) Description and Business Overview
Table 61. Astellas Pharma (Japan) IBS Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in IBS Treatment Business of Astellas Pharma (Japan) (2024-2024)
Table 63. Astellas Pharma (Japan) Recent Developments
Table 64. Bausch Health Basic Information List
Table 65. Bausch Health Description and Business Overview
Table 66. Bausch Health IBS Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in IBS Treatment Business of Bausch Health (2024-2024)
Table 68. Bausch Health Recent Developments
Table 69. Abbott Laboratories (U.S.) Basic Information List
Table 70. Abbott Laboratories (U.S.) Description and Business Overview
Table 71. Abbott Laboratories (U.S.) IBS Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in IBS Treatment Business of Abbott Laboratories (U.S.) (2024-2024)
Table 73. Abbott Laboratories (U.S.) Recent Developments
Table 74. Synergy Pharmaceuticals (U.S.) Basic Information List
Table 75. Synergy Pharmaceuticals (U.S.) Description and Business Overview
Table 76. Synergy Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in IBS Treatment Business of Synergy Pharmaceuticals (U.S.) (2024-2024)
Table 78. Synergy Pharmaceuticals (U.S.) Recent Developments
Table 79. Ardelyx (U.S.) Basic Information List
Table 80. Ardelyx (U.S.) Description and Business Overview
Table 81. Ardelyx (U.S.) IBS Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in IBS Treatment Business of Ardelyx (U.S.) (2024-2024)
Table 83. Ardelyx (U.S.) Recent Developments
Table 84. Nestle (Switzerland) Basic Information List
Table 85. Nestle (Switzerland) Description and Business Overview
Table 86. Nestle (Switzerland) IBS Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in IBS Treatment Business of Nestle (Switzerland) (2024-2024)
Table 88. Nestle (Switzerland) Recent Developments
Table 89. Sebela Pharmaceuticals (Ireland) Basic Information List
Table 90. Sebela Pharmaceuticals (Ireland) Description and Business Overview
Table 91. Sebela Pharmaceuticals (Ireland) IBS Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in IBS Treatment Business of Sebela Pharmaceuticals (Ireland) (2024-2024)
Table 93. Sebela Pharmaceuticals (Ireland) Recent Developments
Table 94. Probi (Sweden) Basic Information List
Table 95. Probi (Sweden) Description and Business Overview
Table 96. Probi (Sweden) IBS Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in IBS Treatment Business of Probi (Sweden) (2024-2024)
Table 98. Probi (Sweden) Recent Developments
Table 99. Alfasigma USA (Italy) Basic Information List
Table 100. Alfasigma USA (Italy) Description and Business Overview
Table 101. Alfasigma USA (Italy) IBS Treatment Products, Services and Solutions
Table 102. Revenue (US$ Million) in IBS Treatment Business of Alfasigma USA (Italy) (2024-2024)
Table 103. Alfasigma USA (Italy) Recent Developments
Table 104. RedHill Biopharma (Israel) Basic Information List
Table 105. RedHill Biopharma (Israel) Description and Business Overview
Table 106. RedHill Biopharma (Israel) IBS Treatment Products, Services and Solutions
Table 107. Revenue (US$ Million) in IBS Treatment Business of RedHill Biopharma (Israel) (2024-2024)
Table 108. RedHill Biopharma (Israel) Recent Developments
Table 109. AstraZeneca (U.K) Basic Information List
Table 110. AstraZeneca (U.K) Description and Business Overview
Table 111. AstraZeneca (U.K) IBS Treatment Products, Services and Solutions
Table 112. Revenue (US$ Million) in IBS Treatment Business of AstraZeneca (U.K) (2024-2024)
Table 113. AstraZeneca (U.K) Recent Developments
Table 114. Ipsen (France) Basic Information List
Table 115. Ipsen (France) Description and Business Overview
Table 116. Ipsen (France) IBS Treatment Products, Services and Solutions
Table 117. Revenue (US$ Million) in IBS Treatment Business of Ipsen (France) (2024-2024)
Table 118. Ipsen (France) Recent Developments
Table 119. Novartis (Switzerland) Basic Information List
Table 120. Novartis (Switzerland) Description and Business Overview
Table 121. Novartis (Switzerland) IBS Treatment Products, Services and Solutions
Table 122. Revenue (US$ Million) in IBS Treatment Business of Novartis (Switzerland) (2024-2024)
Table 123. Novartis (Switzerland) Recent Developments
Table 124. Takeda Pharmaceutical Company (Japan) Basic Information List
Table 125. Takeda Pharmaceutical Company (Japan) Description and Business Overview
Table 126. Takeda Pharmaceutical Company (Japan) IBS Treatment Products, Services and Solutions
Table 127. Revenue (US$ Million) in IBS Treatment Business of Takeda Pharmaceutical Company (Japan) (2024-2024)
Table 128. Takeda Pharmaceutical Company (Japan) Recent Developments
Table 129. Synthetic Biologics (U.S.) Basic Information List
Table 130. Synthetic Biologics (U.S.) Description and Business Overview
Table 131. Synthetic Biologics (U.S.) IBS Treatment Products, Services and Solutions
Table 132. Revenue (US$ Million) in IBS Treatment Business of Synthetic Biologics (U.S.) (2024-2024)
Table 133. Synthetic Biologics (U.S.) Recent Developments
Table 134. Protagonist Therapeutics (U.S.) Basic Information List
Table 135. Protagonist Therapeutics (U.S.) Description and Business Overview
Table 136. Protagonist Therapeutics (U.S.) IBS Treatment Products, Services and Solutions
Table 137. Revenue (US$ Million) in IBS Treatment Business of Protagonist Therapeutics (U.S.) (2024-2024)
Table 138. Protagonist Therapeutics (U.S.) Recent Developments
Table 139. Pfizer (U.S.) Basic Information List
Table 140. Pfizer (U.S.) Description and Business Overview
Table 141. Pfizer (U.S.) IBS Treatment Products, Services and Solutions
Table 142. Revenue (US$ Million) in IBS Treatment Business of Pfizer (U.S.) (2024-2024)
Table 143. Pfizer (U.S.) Recent Developments
Table 144. Lexicon Pharmaceuticals (U.S.) Basic Information List
Table 145. Lexicon Pharmaceuticals (U.S.) Description and Business Overview
Table 146. Lexicon Pharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
Table 147. Revenue (US$ Million) in IBS Treatment Business of Lexicon Pharmaceuticals (U.S.) (2024-2024)
Table 148. Lexicon Pharmaceuticals (U.S.) Recent Developments
Table 149. Innovate Biopharmaceuticals (U.S.) Basic Information List
Table 150. Innovate Biopharmaceuticals (U.S.) Description and Business Overview
Table 151. Innovate Biopharmaceuticals (U.S.) IBS Treatment Products, Services and Solutions
Table 152. Revenue (US$ Million) in IBS Treatment Business of Innovate Biopharmaceuticals (U.S.) (2024-2024)
Table 153. Innovate Biopharmaceuticals (U.S.) Recent Developments
Table 154. North America IBS Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 155. North America IBS Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 156. Europe IBS Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 157. Europe IBS Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 158. Asia-Pacific IBS Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 159. Asia-Pacific IBS Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 160. Asia-Pacific IBS Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 161. Asia-Pacific IBS Treatment Market Share by Region (2024-2024)
Table 162. Asia-Pacific IBS Treatment Market Share by Region (2024-2034)
Table 163. Latin America IBS Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 164. Latin America IBS Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 165. Latin America IBS Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 166. Middle East & Africa IBS Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 167. Middle East & Africa IBS Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 168. Middle East & Africa IBS Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 169. IBS Treatment Market Trends
Table 170. IBS Treatment Market Drivers
Table 171. IBS Treatment Market Challenges
Table 172. IBS Treatment Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IBS Treatment Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global IBS Treatment Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global IBS Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global IBS Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America IBS Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe IBS Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific IBS Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America IBS Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa IBS Treatment Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of IBS-D
Figure 11. Global IBS-D Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of IBS-C
Figure 13. Global IBS-C Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of IBS-M
Figure 15. Global IBS-M Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global IBS Treatment Market Size Share by Type: 2022 & 2034
Figure 17. North America IBS Treatment Revenue Market Share by Type (2024-2034)
Figure 18. Europe IBS Treatment Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific IBS Treatment Revenue Market Share by Type (2024-2034)
Figure 20. Latin America IBS Treatment Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa IBS Treatment Revenue Market Share by Type (2024-2034)
Figure 22. Hospitals Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Clinics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Research Laboratories Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global IBS Treatment Market Size Share by Application: 2022 & 2034
Figure 26. North America IBS Treatment Revenue Market Share by Application (2024-2034)
Figure 27. Europe IBS Treatment Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific IBS Treatment Revenue Market Share by Application (2024-2034)
Figure 29. Latin America IBS Treatment Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa IBS Treatment Revenue Market Share by Application (2024-2034)
Figure 31. IBS Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players IBS Treatment Market Share in 2022
Figure 33. North America IBS Treatment Market Share by Country (2024-2034)
Figure 34. U.S. IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 35. Canada IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 36. Germany IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 37. France IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 39. Italy IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 40. Russia IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific IBS Treatment Market Share by Region (2024-2034)
Figure 43. China IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 44. Japan IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 47. India IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 48. Australia IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America IBS Treatment Market Share by Country (2024-2034)
Figure 50. Mexico IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa IBS Treatment Market Share by Country (2024-2034)
Figure 53. Turkey IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 55. UAE IBS Treatment Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report